People whose Alzheimer’s disease gets diagnosed as part of a health crisis have much higher costs than those in whom screening shows significant cognitive issues.
Men with advanced prostate cancer taking abiraterone or enzalutamide plus hormone therapy were at higher risk of serious medical issues than their peers undergoing hormone therapy alone.
Bradley Zebrack reflects on the insights he’s applied from his cancer journey to his job.
Research unravels the mystery of how one of the X chromosomes in female embryonic stem cells is silenced
Poll shows most people over 50 feel their health is the same or better than before 2020, but also reveals subgroups that may need more support to achieve healthy aging
Which hospice they enter, rather than their condition, may determine which patients receive antipsychotics or benzodiazepines to quell end-of-life symptoms.
Eighty percent of patients with a subset of lymphoma saw their cancers shrink after taking zanubrutinib in a clinical trial.
The doctor who helped lead Michigan’s response for more than a year reflects on lessons learned.
One physician's journey from Ghana to the states, and how her passion paved the way for her to become a surgeon.
University of Michigan medical students answer pre-meds’ questions ranging from how to prepare for interviews to how to stay well while juggling medical school.
Known as HIPEC, the therapy has been available for adults for years at Michigan Medicine. Now it’s an option for kids here, too.
Specialists offer coping strategies to share with families.
A key Supreme Court ruling expected soon, and other policies and proposals playing out at the state and federal level.